A Medicalization-Only Model Limits the Psychedelic Experience
Journalist Rich Haridy discusses his concerns with boxing psychedelics into a medicalized container.
Psymposia
Watch
All videos
Australian Bush Doofs and Psychedelic Commercialization (w/ Dr. Sam Douglas & Rich Haridy)
Russell, Mike, and Neşe sit down with journalist Rich Haridy and Dr. Samuel Douglas to discuss bush doofs, Australian psychedelic commercialization, Entheogenesis Australis, Haridy's new book, and more.
Psymposia's Psychedelic Patreon Pop Quiz
This video was originally aired as Patreon-only content. Check us out on Patreon at www.patreon.com/psymposia
Psymposia Aesthetics: Team Portrait Illustrations
This video originally aired as Patreon-only content. Check us out on Patreon at www.patreon.com/psymposia
Psymposia Aesthetics: Right-Wing Psychedelia Collage
This video was first aired as Patreon-exclusive content. Check out our Patreon at www.patreon.com/psymposia.
Psymposia Aesthetics: Volume #1
This video originally aired on our Patreon. You can find us there at www.patreon.com/psymposia
The Deluded Beliefs of Psychedelic Therapy Advocates
The crew discusses two presenters at the September 14, 2026 FDA public hearing on psychedelics, and the way that Silicon Valley and new age pseudoscience are coming together to create the back bone of the psychedelic therapy industry's ideology.
Psymposia Mailbag (September 2026)
The crew reads comments on their recent conversion therapy, Reggie Watts, and Alex Novell videos.
MAHA Summit — Brought to You by Psychedelic Pharma
Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.
Featured investigation
The Psychedelic Syndicate: Executive Summary
A year-long investigation reveals how a small group of Silicon Valley elites sought to capture the psychedelic therapy industry — using a network of affiliated organizations to scapegoat critics while pressuring regulators to approve their botched MDMA clinical trials.
The Psychedelic Syndicate: Part 1
Part 1 of The Psychedelic Syndicate reveals how the Psychedelic Science Funders Collaborative (PSFC) — a wealthy network of Silicon Valley elites and Burning Man devotees — systematically captured the psychedelic movement by influencing MAPS, funding its subsidiary Lykos’ MDMA clinical trials, and…
The Psychedelic Syndicate: Part 2
Part 2 of The Psychedelic Syndicate exposes the compromised foundation of PSFC’s influence network — from the abuse scandals that undermined their preferred therapy model, to undisclosed ties with the sole FDA advisory committee member who voted unequivocally for MDMA approval.
The Psychedelic Syndicate: Part 3
Part 3 of The Psychedelic Syndicate exposes how Silicon Valley’s “move fast and break things” mentality infected psychedelic therapy, creating a culture where leaders rationalized patient harm as unavoidable for progress and ultimately embraced Trump administration officials who promised…
The Psychedelic Syndicate: Part 4
Part 4 of The Psychedelic Syndicate reveals PSFC’s strategy to manufacture spiritual and moral authority through academic capture — even as some members align with far-right ideologies that deepen the very crises psychedelics are meant to heal.
Featured series
Hamilton’s Pharma Cope
In this conversation we address Hamilton Morris’ misinformation head on, exposing Morris’ lies and his lack of journalistic integrity.
Watch the series
Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript
In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.
Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript
In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.
Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Psychedelic Conversion Therapy
A three-part series on the past, present and future of psychedelic conversion therapy: its history in psychedelic research, the influencers who pathologize queerness, and what it means to welcome pro-conversion therapy advocates into a movement built around “healing.”
Watch the series
Psychedelic Conversion Therapy, Part 1: The First Wave
Neşe and Russell review the history and harms of conversion therapy practices in the broader medical landscape, as well as their persistence throughout the history of psychedelic research.
Psychedelic Conversion Therapy, Part 2: From Counterculture to Culture War
Neşe and Russell examine the rise of modern right-wing influencers who simultaneously advocate for the dismantling of “woke” ideologies, express support for conversion therapy frameworks, and promote the use of psychedelic therapy.
Psychedelic Conversion Therapy, Part 3: A Handshake Away From Trump (w/ Kaleb Graves)
Neşe and Russell speak with Kaleb Graves about his reporting on the growing links between psychedelic therapy and conversion therapy movements.
Statements
Correcting the Record: What The New York Times Got Wrong
In response to The New York Times February 4 article, “How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy,” Psymposia requested corrections to numerous errors and false accusations.
Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia
Rather than unpacking the actual causes of Lykos Therapeutics’ disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health.